$HESM

Hess Midstream (HESM) Cut to Underweight by Morgan Stanley on Risk-Reward Concerns

Morgan Stanley downgraded Hess Midstream LP (HESM) to Underweight from Equal Weight on June 10, citing limited visibility into long-term growth and sponsor strategy, and an unfavorable risk/reward. It set a $38 price target. In its Q1 2026 call, CEO Jonathan Stein said the firm completed a $60 million share/unit repurchase in March and increased Class A distributions by 2% (about 8% annualized).

Original reporting
Published Jun 19, 2026, 7:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 19, 2026, 7:40 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Hess Midstream (HESM) Cut to Underweight by Morgan Stanley on Risk-Reward Concerns — source image
Decision brief

The 30-second read

$HESMBearishMed
01

Why it matters

The downgrade is the actionable catalyst, while the earnings-call details (repurchase, distribution increase, throughput, and planned maintenance) provide context for whether the market should treat the risk-reward reset as justified.

02

Market read

A sell-side downgrade with a specific price target and thesis can drive near-term positioning in a high-dividend midstream name, even as management reiterates guidance.

03

What to watch

The article notes planned TGP maintenance reducing volumes by 5–10 MMcf/d in Q2; traders may be underweighting how temporary volume pressure could affect near-term results versus the longer-term thesis cited by Morgan Stanley.

Relevance 7/10Novelty 7/10Timing: post-downgrade positioning after the June 10 analyst cut

Background

The piece centers on a June 10 Morgan Stanley downgrade to Underweight for Hess Midstream, alongside CEO remarks from the first-quarter 2026 earnings call.

Company-level read

Ticker impact

$HESMBearishMedium confidence
Context

Morgan Stanley downgraded Hess Midstream LP to Underweight from Equal Weight and set a $38 price target citing constrained upside.

Expected impact

Likely downside bias and elevated volatility around analyst-follow-through; magnitude depends on how the market prices the downgrade versus dividend/throughput updates.

Evidence & confidence

The article’s newest decision is the June 10 downgrade with a stated thesis (limited long-term growth visibility, sponsor strategy overhang). The rest (buyback, distribution increase, throughput, maintenance volume impact) is supportive but not framed as a new surprise event.

Market effects

Analyst caution on midstream sponsor strategy and long-term growth visibility can pressure sentiment across income-focused midstream names.

No specific regional catalyst beyond US-listed analyst action.

Limited; this is primarily a single-name sell-side risk-reward update.

Counterpoint

The CEO’s commentary on accretive repurchases, a 2% distribution increase, and guidance/volume growth could offset the downgrade if investors prioritize cash yield and execution over long-term sponsor strategy.

Key entities

  • Hess Midstream LP

    Subject of the downgrade; midstream operator with dividend yield and ongoing distribution/repurchase activity.

  • Morgan Stanley

    Issued the Underweight downgrade and set a $38 price target citing constrained upside and overhang risk.

  • Jonathan Stein

    CEO who discussed repurchases, distribution increase, throughput, and planned maintenance volume impacts.

Related articles

$HESMMed

Why is Hess Midstream Partners stock rallying today?

Hess Midstream Partners shares rose 2.6% pre-open after the company reported Q2 2026 results. Adjusted EPS per unit was $0.75 vs $0.69 consensus, and revenue was $399M vs $396.46M. The firm reaffirmed full-year guidance and declared a quarterly cash distribution of about $0.789 per Class A share, with ex-dividend Aug. 6.

$GDDYMed

Wall Street Is Losing Confidence in GoDaddy’s (GDDY) AI Strategy. Should Investors?

GoDaddy (NYSE:GDDY) reported Q results of $1.83 EPS and about $1.30B revenue, both above consensus, but the stock fell about 12%. Bookings rose 6% to $1.4B, while Applications and Commerce bookings growth slowed to 7% from 9%. Analysts cited concerns over agentic AI transition noise; management is accelerating Airo and cutting legacy investment. Q3 revenue guidance is $1.32B-$1.34B.

$BAMed

Boeing's 777X Headache Just Got Worse: Lufthansa Says No Thanks

Lufthansa said it will not accept the earliest built examples of Boeing’s 777-9, joining Emirates, as some aircraft have been in storage since 2019-2020. Boeing’s 777X program remains uncertified and is now about 6-7 years behind schedule, with certification targeted for late 2026 or early 2027 and first Lufthansa deliveries in Q1 2027. Boeing took a $4.9B pre-tax charge in 2025.

$DVAMed

DaVita Shares Rise After TD Cowen Upgrades Stock to Buy

DaVita HealthCare Partners (NYSE:DVA) rose about 2.1% premarket after TD Cowen upgraded it from Hold to Buy and raised its price target to $220 from $201, citing improving competitive position and long-term growth. The upgrade followed DaVita’s Q2 2026 results: adjusted EPS $4.02 vs $3.92 expected, revenue about $3.55B vs estimates, while guidance stayed unchanged.